Concepedia

Guillermo Yoldi

GY

Statistics

Publications

12

Citations

1.2K

H-Index

11

Active since

1987

Affiliations

Institut d'Investigació Biomédica de Bellvitge(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Universitat Autònoma de Barcelona

Institut Català d'Oncologia

Vall d'Hebron Institut de Recerca

Guillermo Yoldi is an author at Institut d'Investigació Biomédica de Bellvitge specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

1987–2022

12

Publications

12

Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More

Giovanni Bonadonna, Umberto Veronesi, Cristina Brambilla et al. · JNCI Journal of the National Cancer Institute · 1990 · 612 citations

, , +7

The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells

Pau Muñoz‐Guardiola, Josefina Casas, Elisabet Megías‐Roda et al. · Autophagy · 2020 · 113 citations · Full text

, , +17

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Clara Gomez‐Aleza, Bastien Nguyen, Guillermo Yoldi et al. · Nature Communications · 2020 · 92 citations · Full text

, , +17

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation

Guillermo Yoldi, Pasquale Pellegrini, Eva M. Trinidad et al. · Cancer Research · 2016 · 74 citations

, , +17

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

Jorge Gómez‐Miragaya, Marta Palafox, Laia Paré et al. · Stem Cell Reports · 2017 · 71 citations · Full text

, , +17

1–5 of 12